Covid-19 roundup: Ger­many puts J&J on the hot­seat for vac­cine back­o­rder; Top EMA of­fi­cial sug­gests for­go­ing As­traZeneca shot

Short­ly af­ter it was an­nounced that the FDA has re­quired J&J to dis­card tens of mil­lions of Covid-19 vac­cines that were con­t­a­m­i­nat­ed at an em­bat­tled Emer­gent plant in Bal­ti­more, MD, Ger­many has de­mand­ed that the com­pa­ny de­liv­er 6.5 mil­lion dos­es to make up for a short­fall, Reuters re­port­ed.

The FDA said Fri­day that two batch­es of the drug sub­stance used in J&J’s jab would be re­leased from quar­an­tine af­ter mil­lions of dos­es were held from dis­tri­b­u­tion at the Emer­gent site. While that frees up about 10 mil­lion dos­es, The New York Times re­port­ed Fri­day morn­ing an­oth­er 60 mil­lion dos­es were or­dered to be tossed out.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER